Good articles about buyout potential from Giliad and others I see stock over time at $30 in one year. Buyout at $20 can happen. The potential for its drug is 4.5B+ that a BIG DEAL.
I am LONG ARWR!!!
Sentiment: Strong Buy
ARWR research shows it back on track with the efficacy for 520. Stock should be trading at $10 soon.
Based on the data and the fall in stock over last 2 years, perhaps it time for ARWR to be back up to mid teens.
Long ARWR!!!! Chah Ching
There are probably some big buys on VRX in the 60's and once the news comes, the stock should be back into $80's in a snap heading to $110 over next month.